APA (7th ed.) Citation

Bhatt, S. P., Freemantle, N., Soliman, M., Heble, J., Cabon, Y., Mayen Herrera, E., . . . Xu, Y. (2026). Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison. Pulmonary Therapy, 12(1), 201. https://doi.org/10.1007/s41030-025-00322-1

Chicago Style (17th ed.) Citation

Bhatt, Surya P., Nick Freemantle, Mena Soliman, Jigna Heble, Yann Cabon, Ernesto Mayen Herrera, Joe Yang, and Yingxin Xu. "Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison." Pulmonary Therapy 12, no. 1 (2026): 201. https://doi.org/10.1007/s41030-025-00322-1.

MLA (9th ed.) Citation

Bhatt, Surya P., et al. "Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison." Pulmonary Therapy, vol. 12, no. 1, 2026, p. 201, https://doi.org/10.1007/s41030-025-00322-1.